Russell Starr joins Streamex as strategic advisor

VANCOUVER & LOS ANGELES - BioSig Technologies, Inc. (Nasdaq:BSGM) announced Friday the appointment of Russell Starr as Strategic Advisor to its subsidiary Streamex Exchange Corporation.

Starr, a former executive on Bay Street and previous CEO of DeFi Technologies, brings experience in capital markets, business development, and deal-making across decentralized finance and traditional finance sectors. With BioSig’s market capitalization currently at $99.12 million and a price-to-book ratio of 61.4, InvestingPro data reveals 12 additional key insights about the company’s financial position and market performance.

During his tenure at DeFi Technologies, Starr led the company’s growth from $0.07 USD to $4.95 USD per share with over $200 million USD in yearly revenue, according to the company statement. After stepping down as CEO, he served as Head of Capital Markets and helped list the company on Nasdaq.

"Russell’s experience in capital markets, natural resources, and decentralized finance make him an exceptional addition to the Streamex advisory team," said Henry McPhie, CEO of BioSig and Co-Founder of Streamex.

Starr joins existing Streamex advisors including Frank Giustra, founder of Wheaton Precious Metals; Sean Roosen, founder of Osisko Development Corp.; Mathew August, Executive Chairman of Atlas Capital Partners; Trevor Bacon, CEO of Parcl; and Kellan Grenier, COO of Parcl.

Streamex, a wholly owned subsidiary of BioSig Technologies, describes itself as a gold treasury and infrastructure company focused on real-world asset tokenization. The company aims to develop a platform combining token issuance, trading infrastructure, and physical gold holdings.

The company plans to hold physical gold through a bullion bank and denominate the majority of its balance sheet in vaulted gold rather than fiat currency, according to the press release. While the company maintains a healthy current ratio of 2.37 and operates with minimal debt, InvestingPro analysis indicates the company’s overall financial health score remains in the weak category, with analysts projecting continued sales decline in the current year.

In other recent news, BioSig Technologies, Inc. has announced significant developments that could impact its future trajectory. The company secured up to $1.1 billion in growth financing to support its gold-backed treasury management strategy, which includes $100 million in senior secured convertible debentures and a $1 billion equity line of credit. This financing follows BioSig’s recent merger with Streamex Exchange Corporation, positioning the company to become a major holder of gold bullion on Nasdaq. In analyst updates, Ascendiant Capital upgraded BioSig’s stock, raising the price target from $2.50 to $10.00, maintaining a Buy rating due to the attractive valuation and high potential market rewards.

Additionally, BioSig has expanded its advisory board by appointing Trevor Bacon and Kellan Grenier, co-founders of Parcl, as strategic advisors to its subsidiary, Streamex Exchange Corporation. Their expertise in decentralized finance is expected to advance BioSig’s initiatives in the commodities market. Furthermore, Sean Roosen, known for his leadership in the mining industry, has also been appointed as a strategic advisor, bringing over 30 years of experience to support Streamex’s mission of tokenizing real-world assets. These appointments are part of BioSig’s strategy to leverage blockchain technology in revolutionizing commodity finance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.